Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer

NCT03202446 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer Stage IIIA
Breast Cancer, Stage IIIB
Breast Cancer Stage IV

Interventions

DRUG: 1% Glycated Chitosan
DEVICE: Photothermal Laser
DRUG: Placebo
DRUG: Cyclophosphamide
DRUG: Standard of Care

Sponsor

Eske Corporation S.A.C